EL7.AI
StocksMediumUpdated•Originally published 13 April 2026•Updated 14 April 2026•
1 min read

Stryker to Acquire Amplitude Vascular Systems to Bolster Cardiovascular Portfolio

Key Facts

1Stryker agreed to acquire Amplitude Vascular Systems (AVS), a firm specializing in intravascular lithotripsy (IVL) technology.
2The financial terms of the acquisition agreement were not disclosed.
3The acquisition aims to bolster Stryker's peripheral vascular portfolio and compete with rivals like Johnson & Johnson and Boston Scientific.

Stryker (NYSE:SYK), headquartered in Portage, Michigan, has signed a definitive agreement to acquire Amplitude Vascular Systems (AVS), a privately held medical technology firm specializing in intravascular lithotripsy (IVL). The acquisition is designed to integrate the Pulse IVL system, which is currently undergoing pivotal trials, into Stryker’s cardiovascular treatment offerings. By incorporating AVS's technology, Stryker aims to strengthen its peripheral vascular portfolio and expand its footprint in high-growth medical markets. This strategic move positions the company to compete more effectively against industry rivals such as Johnson & Johnson and Boston Scientific. While the acquisition marks a significant expansion, the specific financial terms of the deal were not disclosed. The transaction underscores Stryker's commitment to advancing treatments for complex artery diseases through targeted innovation.